Why the study?
Do genetic variants in lipid metabolism genes associate with CAD and future cardiovascular events in an Italian population?
Do genetic variants in lipid metabolism genes associate with CAD and future cardiovascular events in an Italian population?
Variations in the LIPC (hepatic lipase) gene are associated with clinical outcomes in Italian patients with established CAD, suggesting a potential genetic marker for secondary cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
LIPC T202T may mark recurrent risk in CAD patients; hypothesis-generating and should not yet change practice.
Baroni et al. (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: